I am deeply shocked by the news that UK tyrants are forcing non-psychoactive CBD products off the market for up to 18 months while they study it, after classification as a "novel food".
An estimated 300,000 people in the UK are using CBD products and finding them beneficial for dealing with many health problems such as anxiety, depression and pain.
This will no doubt drive people back to pharmaceutical drugs that often have possible serious side-effects and warnings on the instruction sheets.
Once again, shame upon the UK Government - and remember it is Theressa May's husband that invests indirectly in GW Pharmaceuticals who make and market expensive Sativex cannabis extracts, and Victoria Atkins, Drug Minister's, husband that holds shares in British Sugar who grow and export tons of "medical cannabis" whilst classifying it as a drug with no medicinal uses.
Watchdogs are set to ban High Street CBD 'cannabis' oil for up to 18 months as experts probe whether it has any real health benefits
Darren Hutchinson *** UPDATE****
Official statement from the FSA:
“As you will be aware, the classification of novel foods is determined by the European Commission and not the FSA.
“Food business operators have been unable to demonstrate a significant history of consumption of Cannabidiol (CBD) extracts in food supplements and food prior to May 1997 in any Member State of the European Union.
“As a result, under the Novel Food Regulations, these extracts are all regarded as novel foods and must be authorised before they can be placed on the market.
“Some products such as hemp seeds, seed oil, hemp seed flour, defatted hemp seed have a history of consumption prior to May 1997 in the EU and are not novel.
“When considering Hemp products, the product may be subject to other legal frameworks depending on the composition and nature of the product. If a product is considered a controlled substance or a medicine it would be outside the definition of food and regulated by those regulatory frameworks.”
“Brexit will not affect the novel food status of CBD as under the Withdrawal Act, the Novel Food Regulations will be transferred to UK law."
Official statement from the FSA:
“As you will be aware, the classification of novel foods is determined by the European Commission and not the FSA.
“Food business operators have been unable to demonstrate a significant history of consumption of Cannabidiol (CBD) extracts in food supplements and food prior to May 1997 in any Member State of the European Union.
“As a result, under the Novel Food Regulations, these extracts are all regarded as novel foods and must be authorised before they can be placed on the market.
“Some products such as hemp seeds, seed oil, hemp seed flour, defatted hemp seed have a history of consumption prior to May 1997 in the EU and are not novel.
“When considering Hemp products, the product may be subject to other legal frameworks depending on the composition and nature of the product. If a product is considered a controlled substance or a medicine it would be outside the definition of food and regulated by those regulatory frameworks.”
“Brexit will not affect the novel food status of CBD as under the Withdrawal Act, the Novel Food Regulations will be transferred to UK law."
No comments:
Post a Comment